Literature DB >> 20851762

The use of thiols by ribonucleotide reductase.

Arne Holmgren1, Rajib Sengupta.   

Abstract

Ribonucleotide reductase (RNR) catalyzes the rate-limiting de novo synthesis of 2'-deoxyribonucleotides from the corresponding ribonucleotides and thereby provides balanced deoxyribonucleotide pools required for error-free DNA replication and repair. The essential role of RNR in DNA synthesis and the use of DNA as genetic material has made it an important target for the development of anticancer and antiviral agents. The most well known feature of the universal RNR reaction in all kingdoms of life is the involvement of protein free radicals. Redox-active cysteines, thiyl radicals, and thiol redox proteins of the thioredoxin superfamily play major roles in the catalytic mechanism. The involvement of cysteine residues in catalysis is common to all three classes of RNR. Taking account of the recent progress in this field of research, this review focuses on the use of thiols in the redox mechanism of RNR enzymes.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851762     DOI: 10.1016/j.freeradbiomed.2010.09.005

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  38 in total

1.  Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis.

Authors:  Michael B Harbut; Catherine Vilchèze; Xiaozhou Luo; Mary E Hensler; Hui Guo; Baiyuan Yang; Arnab K Chatterjee; Victor Nizet; William R Jacobs; Peter G Schultz; Feng Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

2.  Glutathione-glutaredoxin is an efficient electron donor system for mammalian p53R2-R1-dependent ribonucleotide reductase.

Authors:  Rajib Sengupta; Lucia Coppo; Pradeep Mishra; Arne Holmgren
Journal:  J Biol Chem       Date:  2019-07-02       Impact factor: 5.157

Review 3.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

Review 4.  Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System.

Authors:  Xiaoyuan Ren; Lili Zou; Xu Zhang; Vasco Branco; Jun Wang; Cristina Carvalho; Arne Holmgren; Jun Lu
Journal:  Antioxid Redox Signal       Date:  2017-05-18       Impact factor: 8.401

Review 5.  Thioredoxin and glutaredoxin-mediated redox regulation of ribonucleotide reductase.

Authors:  Rajib Sengupta; Arne Holmgren
Journal:  World J Biol Chem       Date:  2014-02-26

Review 6.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

Review 7.  Redox regulation of immunometabolism.

Authors:  Jonathan Muri; Manfred Kopf
Journal:  Nat Rev Immunol       Date:  2020-12-18       Impact factor: 53.106

8.  Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1.

Authors:  Justin R Prigge; Sofi Eriksson; Sonya V Iverson; Tesia A Meade; Mario R Capecchi; Elias S J Arnér; Edward E Schmidt
Journal:  Free Radic Biol Med       Date:  2011-12-08       Impact factor: 7.376

9.  Identification and immunological characterization of thioredoxin transmembrane-related protein from Clonorchis sinensis.

Authors:  Chenhui Zhou; Meng Bian; Hua Liao; Qiong Mao; Ran Li; Juanjuan Zhou; Xiaoyun Wang; Shan Li; Chi Liang; Xuerong Li; Yan Huang; Xinbing Yu
Journal:  Parasitol Res       Date:  2013-02-13       Impact factor: 2.289

10.  Increasing discordant antioxidant protein levels and enzymatic activities contribute to increasing redox imbalance observed during human prostate cancer progression.

Authors:  Luksana Chaiswing; Weixiong Zhong; Terry D Oberley
Journal:  Free Radic Biol Med       Date:  2013-11-22       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.